Your institution may have access to this item. Find your institution then sign in to continue.
Title
Safety and efficacy of combination therapy with fludarabine, mitoxantrone, and rituximab followed by yttrium-90 ibritumomab tiuxetan and maintenance rituximab as front-line therapy for patients with follicular or marginal zone lymphoma.
Authors
Karmali, Reem; Kassar, Mohamad; Venugopal, Parameswaran; Shammo, Jamile M.; Fung, Henry C.; Bayer, Robert; O'Brien, Teresa; Gregory, Stephanie A.